长期使用他汀类药物与脑出血风险的关联:一项丹麦全国性病例对照研究
结果显示,当前使用他汀及使用时间越长,脑出血风险越低,趋势检验有统计学意义。
要点
- 当前使用他汀与脑出血风险降低相关(aOR 0.74,95%CI 0.71-0.78)。
- 当前他汀使用时间越长,脑出血风险越低,趋势检验P<0.001。
- 高强度他汀治疗中,使用≥10年者aOR 0.46(95%CI 0.33-0.65)。
核心结论
- 长期使用他汀类药物与脑出血风险降低相关。
主要发现
- 当前使用他汀者脑出血风险低于未使用者(病例25.9% vs 对照24.5%;aOR 0.74,95%CI 0.71-0.78)。
- 当前他汀使用时间与脑出血风险呈负相关:<1年aOR 0.86(95%CI 0.81-0.92),≥1至<5年aOR 0.72(95%CI 0.68-0.76),≥5至<10年aOR 0.65(95%CI 0.60-0.71),≥10年aOR 0.53(95%CI 0.45-0.62),趋势检验P<0.001。
- 高强度他汀治疗中,使用<1年aOR 0.78(95%CI 0.66-0.93),使用≥10年aOR 0.46(95%CI 0.33-0.65),趋势检验P=0.001。
关键数值与推荐
- 当前使用他汀与脑出血风险降低相关(aOR 0.74,95%CI 0.71-0.78)。
- 当前他汀使用≥10年与脑出血风险降低相关(aOR 0.53,95%CI 0.45-0.62)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: A causal relationship between long-term statin use and the risk of intracerebral hemorrhage (ICH) remains uncertain. We investigated the association with statin use before hospital admission for ICH in a Danish population-based, nationwide case-control study. METHODS: We used the Danish Stroke Registry to identify all patients aged 45 years or older with a first-ever ICH between 2005 and 2018. Patients with ICH were matched for age, sex, and calendar year to controls selected from the general population. A medication registry with information on all dispensed prescriptions at community pharmacies in Denmark since 1995 was used to ascertain previous statin exposure that was classified for recency, duration, and intensity. Using conditional regression and adjusting for potential confounders, we calculated adjusted odds ratios (aORs) and corresponding 95% CIs for the risk of ICH. RESULTS: The study population consisted of 16,235 patients with ICH and 640,943 controls. Current statin use (cases 25.9% vs controls 24.5%; aOR 0.74, 95% CI, 0.71-0.78) and a longer duration of current statin use (<1 year: aOR 0.86; 95% CI, 0.81-0.92; ≥1 to <5 years: aOR 0.72; 95% CI, 0.68-0.76; ≥5 to <10 years: aOR 0.65; 95% CI, 0.60-0.71; ≥10 years of use, 0.53; 95% CI 0.45-0.62; p for trend <0.001) were associated with a lower risk of ICH. Similar treatment duration relationships were found in analyses stratified by statin use intensity (high-intensity therapy: <1 year of use: aOR 0.78; 95% CI, 0.66-0.93; ≥10 years of use: aOR 0.46; 95% CI 0.33-0.65; p for trend 0.001). DISCUSSION: We found that a longer duration of statin use was associated with a lower risk of ICH. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that current statin use and a longer duration of statin use are each associated with a lower risk of ICH.
引用
- Rudolph DA, Hald SM, García Rodríguez LA, et al. Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study. Neurology. 2022. PMID: 35577575. doi:10.1212/WNL.0000000000200713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。